HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC

Conditions: Hepatocellular Carcinoma Interventions: Drug: HAIC+STRIDE+Len Sponsors: Sulai Liu Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials